Sanders Investigates Excessive Pricing of Ozempic and Wegovy in Senate

Senator Bernie Sanders is investigating the high prices of the drugs Ozempic and Wegovy, calling out Novo Nordisk for charging “outrageously high prices.” The drugs are used to treat diabetes and obesity and are priced significantly higher in the US compared to other countries. Sanders is questioning Novo Nordisk about pricing, profit, and research costs. The company stated it is committed to supporting access and affordability. The high prices are impacting patients, Medicare, and potentially leading to higher premiums for beneficiaries. The federal government spent billions on Ozempic in 2022, and Wegovy’s approval for reducing the risk of heart attacks and strokes will add to costs.

Read more on www.cnn.com